ALLERGEN, INDIVIDUAL - DRUG TETRACYCLINE

The ALLERGEN, INDIVIDUAL - DRUG TETRACYCLINE test is a targeted laboratory assay designed to detect immune sensitization to tetracycline-class antibiotics by measuring tetracycline-specific IgE antibodies in a blood sample. Samples are collected at-home by a licensed phlebotomist and analysed by an accredited laboratory in Dubai/UAE, providing a quantitative result to support clinical decision-making. This test is primarily used to assess immediate (IgE-mediated) hypersensitivity and helps identify patients at risk of allergic reactions to tetracycline.

This test is suitable for individuals who experienced urticaria, angioedema, respiratory symptoms, or anaphylaxis shortly after tetracycline exposure, and for clinicians who need objective data to guide safe antibiotic selection. Results can be used alongside patient history, specialist evaluation, or skin testing where appropriate; a negative specific IgE does not completely exclude non-IgE-mediated or delayed drug reactions. Always review results with a physician or allergist to determine the best management and alternative therapies in the Dubai/UAE healthcare context.

• Tetracycline-specific IgE (kUA/L)
• Total IgE (IU/mL) — when performed
• Quantitative result with reference range
• Result interpretation: Positive / Negative
• Assay method (Immunoassay e.g., FEIA/ELISA)

• Immediate allergic symptoms after taking tetracycline (hives, swelling, breathing difficulty)
• History of anaphylaxis or severe urticaria temporally related to tetracycline
• Patient-reported antibiotic allergy when considering tetracycline prescription
• Unexplained drug rashes or recurrent reactions after tetracycline exposure
• To guide antibiotic selection in patients with multiple drug allergies

• Accurate detection of tetracycline-specific IgE to identify immediate hypersensitivity
• Certified laboratory analysis with reports suitable for Dubai/UAE clinicians
• Convenient in-home sample collection across Dubai and the UAE
• Quantitative, actionable results to inform safe prescribing decisions
• Rapid turnaround and clear interpretation notes for follow-up care

• In-home venous blood collection by a licensed phlebotomist (available in Dubai/UAE)
• No fasting required prior to testing
• Inform provider of recent antihistamines, systemic steroids, immunosuppressants or IVIG, as these may affect results
• Provide Emirates ID and complete medical history/consent form before sample collection